Leerink Swann initiates coverage on Sophiris Bio (NASDAQ: SPHS) with a Outperform. PT $11.00.

"Our due diligence with MEDACorp ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE